References
- Mebust W K, Holtgrewe H L, Cockett A TK, Peters P C. Transurethral prostatectomy: immediate and postoperative complications. A co-operative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243–7
- Melchior J, Valk W L, Foret J D, Mebust W K. Transurethral prostatectomy: computerised analysis of 2223 consecutive cases. J Urol 1974; 112: 634
- Holtgrewe H L, Valk W L. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2015 cases. J Urol 1962; 87: 450
- Ganabathi K, Roskamp D, Foote J, et al. Prospective urodynamic evaluation of the efficacy of prostatic balloon dilatation. Neuro Urol Urodyn 1992; 11: 483–95
- Lepor H. Medical therapy for benign prostatic hyperplasia. Urology 1993; 42: 483–501
- Costello A J, Brusher W G, Bolton D M, et al. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992; 69: 603–8
- Schlegel P N, Brendler C B. Management of urinary retention due to benign prostatic hyperplasia using luteinizing hormone releasing hormone agonist. Urology 1989; 34(2)69–72
- McLoughlin J, Jager R, Abel P D, et al. The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report. Br J Urol 1990; 66: 66–70
- Kohler-Ockmore J, Feneley R CL. Long-term catheter-isation of the bladder: prevalence and morbidity. Br J Urol 1996; 77: 347–51
- Harrison N W, De Souza J V. Prostatic stenting for outflow obstruction. Br J Urol 1990; 65: 192–6
- Chiou R K, Chen W S, Akbari A, et al. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia. Urology 1996; 48: 589–93
- Kaplan S A, Chiou R K, Morton W J, Katz P G. Long-term experience utilizing a new balloon expandable prostatic endoprosthesis: the TITAN stent. Urology 1995; 45: 234–40
- Dixon C M, Lepor H. Laser ablation of the prostate. Semin Urol 1992; 10: 273–7
- Sonn D J, Copal H B. Complications of laser prostatectomy. J Endourol 1995; 9(2)183–7
- Anson K, Nawrocki J, Buckley J, et al. A multicenter, randomised, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995; 46(3)305–10
- Leach G E, Sirls L, Ganabathi K, et al. Outpatient visual laser-assisted prostatectomy under local anaesthesia. Urology 1994; 43: 149–53
- Glynn R J, Campion E W, Bouchard G R, Silbert J E. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 1985; 121: 78–90
- Roos I MP, Ramsey E W. A population based study of prostatectomy: outcomes associated with differing surgical approaches. J Urol 1987; 137: 1184–8
- Malone P R, Cook A, Edmonson R, et al. Prostatectomy: patients' perception and long term follow-up. Br J Urol 1988; 61: 234–8
- Johnson D E, Levinson A K, Greskovich F J. Transurethral laser prostatectomy using a right-angle laser delivery system. Lasers Urol Laparosc Gen Surg 1991; 1421: 36–41
- Kabalin J N, Gill H S, Leach G E, et al. Prospective multicenter Prolase II clinical trial of neodymium:yttrium-aluminium-garnet laser prostatectomy. Urology 1997; 50(1)63–5
- Akalin Z, Mingan N A, Basar H, et al. Transurethral resection of the prostate and laser prostatectomy under local anaesthesia. Eur Urol 1998; 33: 202–5
- Muschter R, De La Rosette J JM, De La Rosette C H, Whitfield H, et al. Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology 1996; 48(2)223–38
- Garraway W M, Collins G N, Lee R J. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469–71
- Emberton M, Neal D E, Black N, et al. The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996; 77: 233–47